Worth Venture Partners, LLC Intercept Pharmaceuticals, Inc. Put Options Transaction History

Worth Venture Partners, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2018 Feb 15, 2019	SELL	$85.79 - $126.46 $5.86 Million - $8.64 Million	-68,300 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$88.49 - $127.55 $4.45 Million - $6.42 Million	50,300 Added 279.44%	68,300 $355,000
Q2 2018 Aug 13, 2018	BUY	$60.0 - $85.67 $1.08 Million - $1.54 Million	18,000 New	18,000 $113,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.